Bio-Rad and Myriad RBM Partner to Commercialize Multiplex Biomarker Kits for Life Science Research

Bio-Rad Laboratories, Inc.

and Myriad RBM, Inc., a wholly owned subsidiary of Myriad Genetics Inc.

today announced that they have partnered to develop and distribute high-quality immunoassay kits. Under the terms of the agreement, Myriad RBM grants Bio-Rad exclusive distribution rights, for research purposes, to the largest catalog of quantitative multiplexed immunoassays currently available to run on the Bio-Plex® 200, Bio-Plex® 3D, and Bio-Plex® MAGPIX™ instruments.